PURPOSE: Strabismic extraocular muscles (EOMs) differ from normal EOMs in structural and functional properties, but the gene expression profile of these two types of EOM has not been examined. Differences in gene expression may inform about causes and effects of the strabismic condition in humans. METHODS: EOM samples were obtained during corrective surgery from patients with horizontal strabismus and from deceased organ donors with normal EOMs. Microarrays and quantitative PCR identified significantly up- and down-regulated genes in EOM samples. Analysis was performed on probe sets with more than 3-fold differential expression between normal and strabismic samples, with an adjusted P value of ≤ 0.05. RESULTS: Microarray analysis showed that 604 genes in these samples had significantly different expression. Expression predominantly was upregulated in genes involved in extracellular matrix structure, and down-regulated in genes related to contractility. Expression of genes associated with signaling, calcium handling, mitochondria function and biogenesis, and energy homeostasis also was significantly different between normal and strabismic EOM. Skeletal muscle PCR array identified 22 (25%) of 87 muscle-specific genes that were significantly down-regulated in strabismic EOMs; none was significantly upregulated. CONCLUSIONS: Differences in gene expression between strabismic and normal human EOMs point to a relevant contribution of the peripheral oculomotor system to the strabismic condition. Decreases in expression of contractility genes and increases of extracellular matrix-associated genes indicate imbalances in EOM structure. We conclude that gene regulation of proteins fundamental to contractile mechanics and extracellular matrix structure is involved in pathogenesis and/or consequences of strabismus, suggesting potential novel therapeutic targets.
PURPOSE: Strabismic extraocular muscles (EOMs) differ from normal EOMs in structural and functional properties, but the gene expression profile of these two types of EOM has not been examined. Differences in gene expression may inform about causes and effects of the strabismic condition in humans. METHODS: EOM samples were obtained during corrective surgery from patients with horizontal strabismus and from deceased organ donors with normal EOMs. Microarrays and quantitative PCR identified significantly up- and down-regulated genes in EOM samples. Analysis was performed on probe sets with more than 3-fold differential expression between normal and strabismic samples, with an adjusted P value of ≤ 0.05. RESULTS: Microarray analysis showed that 604 genes in these samples had significantly different expression. Expression predominantly was upregulated in genes involved in extracellular matrix structure, and down-regulated in genes related to contractility. Expression of genes associated with signaling, calcium handling, mitochondria function and biogenesis, and energy homeostasis also was significantly different between normal and strabismic EOM. Skeletal muscle PCR array identified 22 (25%) of 87 muscle-specific genes that were significantly down-regulated in strabismic EOMs; none was significantly upregulated. CONCLUSIONS: Differences in gene expression between strabismic and normal human EOMs point to a relevant contribution of the peripheral oculomotor system to the strabismic condition. Decreases in expression of contractility genes and increases of extracellular matrix-associated genes indicate imbalances in EOM structure. We conclude that gene regulation of proteins fundamental to contractile mechanics and extracellular matrix structure is involved in pathogenesis and/or consequences of strabismus, suggesting potential novel therapeutic targets.
Authors: L Domenici-Lombardo; M Corsi; R Mencucci; M Scrivanti; M S Faussone-Pellegrini; G Salvi Journal: Ophthalmologica Date: 1992 Impact factor: 3.250
Authors: S A Crawford; S R Costford; C Aguer; S C Thomas; R A deKemp; J N DaSilva; D Lafontaine; M Kendall; R Dent; R S B Beanlands; R McPherson; M-E Harper Journal: Diabetologia Date: 2010-05-15 Impact factor: 10.122
Authors: Andrew R Kuhn; Karen Schlauch; Ronna Lao; Andrew J Halayko; William T Gerthoffer; Cherie A Singer Journal: Am J Respir Cell Mol Biol Date: 2009-06-18 Impact factor: 6.914
Authors: Mark M G Walton; Adam Pallus; Jérome Fleuriet; Michael J Mustari; Kristina Tarczy-Hornoch Journal: J Neurophysiol Date: 2017-04-12 Impact factor: 2.714
Authors: Abou Yobi; Karen A Schlauch; Richard L Tillett; Won C Yim; Catherine Espinoza; Bernard W M Wone; John C Cushman; Melvin J Oliver Journal: BMC Plant Biol Date: 2017-03-28 Impact factor: 4.215
Authors: Anne Y Fennell; Karen A Schlauch; Satyanarayana Gouthu; Laurent G Deluc; Vedbar Khadka; Lekha Sreekantan; Jerome Grimplet; Grant R Cramer; Katherine L Mathiason Journal: Front Plant Sci Date: 2015-11-04 Impact factor: 5.753
Authors: Supakan Rattanakon; Ryan Ghan; Gregory A Gambetta; Laurent G Deluc; Karen A Schlauch; Grant R Cramer Journal: BMC Plant Biol Date: 2016-03-22 Impact factor: 4.215